Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Following publication of the original article [1], the authors reported an error in their listed affiliations.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | http://link.springer.com/article/10.1186/s40425-018-0487-7 |
id |
doaj-6f76a938d1904fb48158213cdb6d7994 |
---|---|
record_format |
Article |
spelling |
doaj-6f76a938d1904fb48158213cdb6d79942020-11-25T01:37:57ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262019-01-01711110.1186/s40425-018-0487-7Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patientsBin Zhao0Hong Zhao1Jiaxin Zhao2The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical UniversityThe Third Affiliated Hospital of Harbin Medical UniversityThe Fourth Affiliated Hospital of Harbin Medical UniversityFollowing publication of the original article [1], the authors reported an error in their listed affiliations.http://link.springer.com/article/10.1186/s40425-018-0487-7 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bin Zhao Hong Zhao Jiaxin Zhao |
spellingShingle |
Bin Zhao Hong Zhao Jiaxin Zhao Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients Journal for ImmunoTherapy of Cancer |
author_facet |
Bin Zhao Hong Zhao Jiaxin Zhao |
author_sort |
Bin Zhao |
title |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
title_short |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
title_full |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
title_fullStr |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
title_full_unstemmed |
Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
title_sort |
correction to: serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients |
publisher |
BMJ Publishing Group |
series |
Journal for ImmunoTherapy of Cancer |
issn |
2051-1426 |
publishDate |
2019-01-01 |
description |
Following publication of the original article [1], the authors reported an error in their listed affiliations. |
url |
http://link.springer.com/article/10.1186/s40425-018-0487-7 |
work_keys_str_mv |
AT binzhao correctiontoseriousadverseeventsandfataladverseeventsassociatedwithnivolumabtreatmentincancerpatients AT hongzhao correctiontoseriousadverseeventsandfataladverseeventsassociatedwithnivolumabtreatmentincancerpatients AT jiaxinzhao correctiontoseriousadverseeventsandfataladverseeventsassociatedwithnivolumabtreatmentincancerpatients |
_version_ |
1725056147371589632 |